Department of Congenital Cardiology, Evelina London Children's Hospital, Guy's and St Thomas' NHS Foundation Trust, London, SE1 7EH, UK.
Department of Cardiology, Tokyo Women's Medical University, Tokyo, 162-0054, Japan.
Curr Cardiol Rep. 2020 Oct 9;22(12):158. doi: 10.1007/s11886-020-01404-z.
Cardiac catheterization therapies to treat or palliate infants, children and adults with congenital heart disease have developed rapidly worldwide in both technical innovation and device development in the previous three decades. By reviewing of current status of novel or development of devices and techniques, we will discuss what is likely to happen in paediatric heart intervention in the next decade.
Recently, biodegradable stents and devices, transcatheter pulmonary valve implantation for the native right ventricle outflow tract and MRI-guided interventions have been progressing rapidly with good immediate to early results. These are expected to be introduced and spread in the next decade although there are still challenges to overcome. The future of paediatric heart intervention is very promising with rapid development of technological progress.
在过去的三十年中,全球范围内在先天性心脏病的治疗和姑息治疗方面,心脏导管治疗技术在技术创新和设备开发方面迅速发展。通过回顾新型设备和技术的现状,我们将讨论在未来十年儿科心脏介入可能发生的情况。
最近,生物可降解支架和装置、用于原生右心室流出道的经导管肺动脉瓣植入术以及 MRI 引导的介入技术发展迅速,即时和早期效果良好。尽管仍有挑战需要克服,但预计这些技术将在未来十年内得到引入和推广。随着技术进步的快速发展,儿科心脏介入的未来前景非常广阔。